Search Results - "percutaneous coronary intervention"

Refine Results
  1. 1

    ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS by V. A. Sulimov

    Published 2016-01-01

    Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interv...

    Full description

    Subjects: “…percutaneous coronary intervention…”
    Get full text
    Article
  2. 2

    Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention by Yaxin Xiong, Ze Meng, Jiuyue Sun, Yucheng Qi, Kuo Wang, Ping Huang, Qiuyue Yang, Renliang Fan, Jiaman Guan, Mingyan Zhao, Xianglin Meng

    Published 2025-06-01

    <b>Background</b>: Postoperative delirium is associated with an increased number of different complications, such as prolonged hospital stay, long-term cognitive impairment, and increased mortality. Therefore, early prediction of delirium after percutaneous coronary intervention (PCI) is...

    Full description

    Subjects: “…percutaneous coronary intervention…”
    Get full text
    Article
  3. 3

    TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 1. EVIDENCE BASE FOR APPLYING A TRANSRADIAL APPROACH by Sh. T. Zhamgyrchiev, A. N. Samko, E. V. Merkulov, V. M. Mironov, I. V. Levitskiy, A. S. Tereshchenko, R. O. Shirokov, A. M. Gerasimov

    Published 2016-06-01

    The use of the radial artery as an approach to percutaneous coronary interventions is becoming increasing popular now. The success of this approach depends on both the accumulated experience of an operator and a health care facility. The paper analyzes an investigation of the comparative characteris...

    Full description

    Subjects: Get full text
    Article
  4. 4

    REGIONAL ALGORITHM OF CARE IN ST ELEVATION MYOCARDIAL INFARCTION by A. Yu. Vafin, A. S. Galyavich

    Published 2016-03-01

    The aim of the study — to present the developed and applied algorithms of ST elevation myocardial infarction (STEMI) patients. The data analyzed on the medical care provision for STEMI in Tatarstan Republic in 2009-2015 y. Application of algorithms with considered regional specifics and resources ma...

    Full description

    Subjects: Get full text
    Article
  5. 5

    Abrupt Pressure Delivery by Samir B. Pancholy, MD, Sanjay Shah, MD, DM, Aman T. Patel, MD, DM, Tejas M. Patel, MD, DM

    Published 2025-07-01

    A 71-year-old man with acute coronary syndrome was found to have multiple severe calcified stenoses in the dominant left circumflex coronary artery. After lesion preparation, the distal lesion was stented. A stent was advanced in the proximal lesion and inflated, but during the deployment inflation,...

    Full description

    Subjects: Get full text
    Article
  6. 6

    Fasting Before Cardiac Catheterization: Still Necessary? A Systematic Review and Meta‐Analysis of Randomized Clinical Trials by Adil Salihu, Stephane Fournier, Sarah Hugelshofer, Quentin Liabot, Victor Weerts, Georgios Tzimas, Valentina Rancati, Clemence Ferlay, Aurelia Zimmerli, Olivier Muller, Henri Lu, Panagiotis Antiochos, Orestis Efthimiou, David Meier

    Published 2025-06-01

    Background Fasting before elective or nonurgent coronary angiography is commonly recommended to reduce the risk of adverse events, such as aspiration pneumonia. This systematic review and meta‐analysis aimed to evaluate the impact of fasting versus nonfasting protocols on patient outcomes and satisf...

    Full description

    Subjects: Get full text
    Article
  7. 7

    RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION by V. A. Sulimov, E. V. Moroz

    Published 2015-12-01

    Aim. To study prevalence of resistance to acetylsalicylic acid, clopidogrel and dual resistance in percutaneous coronary intervention (PCI), to identify clinical risk factors of resistance development, to study effects of concomitant therapy on resistance development, to identify relationship betwee...

    Full description

    Subjects: Get full text
    Article
  8. 8

    Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention by A. I. Abdrahmanova, N. A. Tsibulkin, N. B. Amirov, I. M. Khabibullin, L. I. Gornaeva, L. A. Galimzyanova, D. S. Elagina

    Published 2022-05-01

    Frequency and timing of appearance of myocardial ischemia, including silent ischemia, were analyzed in published scientific sources. Silent myocardial ischemia is risk factor for stent restenosis after percutaneous coronary interventions. Patients with silent ischemia lack clinical symptoms while pe...

    Full description

    Subjects: Get full text
    Article
  9. 9

    ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? by Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein

    Published 2015-09-01

    The review presents recent data on the usage of platelet functional tests in patients with ischemic heart disease after percutaneous coronary intervention and its contribution to antiplatelet therapy personalization and cardiovascular events frequency reduction.

    Subjects: Get full text
    Article
  10. 10

    Myocardial Infarction in the Postpartum Period by O. B. Shakhova, I. M. Kuzmina, T. R. Gvindzhiliya, M. M. Damirov, N. A. Muradyan, M. V. Parkhomenko

    Published 2022-09-01

    The study objective Is to present a clinical observation, describe the diagnostics and treatment of acute transmural myocardial infarction in a patient on the 8th day after childbirthMaterial and methods A 31-year-old patient was hospitalized 3 hours after the onset of the disease on the 8th day aft...

    Full description

    Subjects: Get full text
    Article
  11. 11

    PROGNOSIS IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION, IN REGARD TO THE PRESENCE OF TYPE 2 DIABETES MELLITUS AND SELECTED TREATMENT STRATEGY IN THE ACUTE PERIOD by Yu. A. Belen’kova, E. V. Tavlueva, V. N. Karetnikova, M. V. Zykov, V. V. Kashtalap, V. N. Ganyukov, O. L. Barbarash

    Published 2012-10-01

    Aim. To assess the results of endovascular revascularisation in patients with acute myocardial infarction (AMI) and ST segment elevation (STEMI), in regard to the presence of Type 2 diabetes mellitus (DM-2), in the real-world clinical settings. Material and methods. The study included 423 STEMI pati...

    Full description

    Subjects: Get full text
    Article
  12. 12

    Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction by S. B. Aksentiev, A. V. Solovieva, D. S. Yunevich

    Published 2021-08-01

    Aim. To compare the efficacy and safety of prasugrel, ticagrelor, or clopidogrel as part of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI) due to myocardial infarction (MI).Material and methods. The observational study included 74 patients who underw...

    Full description

    Subjects: Get full text
    Article
  13. 13

    PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE? by Yu. A. Karpov, I. L. Kozlovskaya, O. S. Bulkina, V. V. Lopukhova

    Published 2018-04-01

    In the article, a role of percutaneous intervention discussed in stable ischemic disease of the heart, and an evolution presented of the perspectives on its influence on prognosis and clinical presentation of the disease. The results provided, of recent trials, including the ORBITA. According to cur...

    Full description

    Subjects: “…percutaneous coronary intervention…”
    Get full text
    Article
  14. 14

    Percutaneous coronary intervention using iso-osmolar contrast agent in an end-stage renal failure patient: a case report by Le Duy Cao Phu’o’ng, Bui Hoa The, Vo Quan Duy

    Published 2025-06-01

    Managing acute myocardial infarction (AMI) in end-stage renal failure (ESRF) patients poses challenges, particularly the risk of contrast-induced nephropathy (CIN) during percutaneous coronary intervention (PCI). This case highlights the successful use of iodixanol, an iso-osmolar contrast agent, in...

    Full description

    Subjects: Get full text
    Article
  15. 15

    STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN by N. G. Gogolashvili

    Published 2015-09-01

    The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.

    Subjects: Get full text
    Article
  16. 16

    Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy by Ziad A. Ali, Ulf Landmesser, Akiko Maehara, Doosup Shin, Koshiro Sakai, Mitsuaki Matsumura, Richard A. Shlofmitz, Giuseppe Calligaris, Aziz Maksoud, Youssef S. Abdelwahed, Paolo Canova, Nieves Gonzalo, Fernando Alfonso, Khady N. Fall, Bassem Chehab, Robert J. McGreevy, Robert W. McNutt, Hong Nie, Jin Wang, Jana Buccola, Gregg W. Stone

    Published 2025-06-01

    Background The optimal management strategy for in‐stent restenosis (ISR) remains unclear. We aimed to determine the safety and efficacy of percutaneous coronary intervention with XIENCE cobalt chromium everolimus‐eluting stents (EES) for treatment of ISR. Methods In the ILUMIEN IV (Optical Coherence...

    Full description

    Subjects: Get full text
    Article
  17. 17

    PHYSICAL TRAINING IN THE REHABILITATION AND PREVENTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PERCUTANEOUS CORONARY INTERVENTIONS: THE BORDERS OF EFFICIENCY AND SAFETY by N. P. Lyamina, E. S. Karpova, E. V. Kotelnikova, E. A. Bizyaeva

    Published 2014-06-01

    Currently, it is proved that physical training (FT) should be a compulsory component of programmes for complex rehabilitation of patients with coronary heart disease after PCI. However, given the heterogeneity of clinical status of patients after conducting PCI medical rehabilitation should be perso...

    Full description

    Subjects: Get full text
    Article
  18. 18

    Late opening of occluded coronary artery in myocardial infarction patients: is it always advisable? by S. V. Shalaev, T. N. Enina

    Published 2007-12-01

    Aim. The study was aimed at verifying a hypothesis: in myocardial infarction (MI) patients with occluded MI‑related coronary artery (IMCA), routine percutaneous coronary intervention is more effective than conservative, pharmacological treatment, for reducing cumulative total mortality risk, risk of...

    Full description

    Subjects: Get full text
    Article
  19. 19

    CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE by K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva

    Published 2015-09-01

    Clinical case history of endovascular intervention in infarct related coronary artery with 4 sirolimus-eluting stents implantation and their further thrombosis during early postoperative period is described. Percutaneous coronary intervention was successful after the balanced medication with 2 antip...

    Full description

    Subjects: Get full text
    Article
  20. 20

    Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Se... by Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy

    Published 2019-03-01

    Background. Eptifibatide achieves high local concentration via direct intracoronary (I/V) injection as it promotes clot disaggregation, but it remains unclear if it is of superior benefit than the routine intravenous (I/V) administration. Aim. The current study aimed to examine the safety and effica...

    Full description

    Subjects: “…primary percutaneous coronary intervention…”
    Get full text
    Article